Intelligence · Clinical Development
Pipeline search results
Programs matching “ropivacaine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 23 pipeline programs matching "ropivacaine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Continuous Gastrocnemius plane block with ropivacaine
The First People's Hospital of Lianyungang
Foot Ankle Injuries
1 trial -
Ropivacaine HCL
Atrium Therapeutics
Renal Carcinoma
1 trial -
SODIUM CHLORIDE, ROPIVACAINE
Pari Pharma GmbH
Cancer surgery
1 trial -
Ropivacaine injection
United Therapeutics Europe Ltd
Stress Disorders, Post-Traumatic
2 trials -
0.3% ropivacaine and 50 μg dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Free Flap Reconstruction
1 trial -
0.33% ropivacaine 250ml
Guangzhou General Hospital of Guangzhou Military Command
Pain
1 trial -
MgSO4 plus Ropivacaine
Hospital Authority, Hong Kong
Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block
1 trial -
ROPIVACAINE , SODIUM CHLORIDE
Disc Medicine
Urolithiasis
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
Radius Fractures
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
End Stage Renal Disease (ESRD)
1 trial -
S-ketamine & Ropivacaine
The First People's Hospital of Lianyungang
Postoperative Analgesia
1 trial -
SODIUM CHLORIDE, ROPIVACAINE HYDROCHLORIDE
Disc Medicine
Total Hip Arthroplasty / THA
1 trial -
Triamcinolone acetonide-Ketorolac-Ropivacaine
United Therapeutics Europe Ltd
Osteoarthritis, Knee
1 trial -
preoperative 0.5% ropivacaine hydrochloride preoperative
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Pain
1 trial -
ropivacaine
The First People's Hospital of Lianyungang
Injury of Upper Limb
1 trial -
Dexmedetomidine ropivacaine
The First People's Hospital of Lianyungang
Pharmacological Action
1 trial -
Hydromorphone combined with ropivacaine
Second Hospital of Jilin University
Inguinal Hernia
1 trial -
Ropivacaine
Zealand Pharma A/S
Pain, Postoperative
1 trial -
Ropivacaine
Hospital Authority, Hong Kong
Liver Diseases
1 trial -
Ropivacaine
Lei Xiaoming
Cystic Adenomatoid Malformation of Lung, Congenital
1 trial -
Ropivacaine
Hospital Authority, Hong Kong
Femoral Fracture
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
Surgery
1 trial -
Ropivacaine Hydrochloride 10 MG/ML [Naropin]
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.